wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33647738-40C29C0F-7FF9-4F33-B745-931270C6890D
Q33647738-40C29C0F-7FF9-4F33-B745-931270C6890D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33647738-40C29C0F-7FF9-4F33-B745-931270C6890D
Review: Complement and its regulatory proteins in kidney diseases.
P2860
Q33647738-40C29C0F-7FF9-4F33-B745-931270C6890D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33647738-40C29C0F-7FF9-4F33-B745-931270C6890D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51816c279d154896a4d02e60012d04ff0123277a
P2860
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.